Eisai files for approval of Alzheimer’s drug in Japan
The drug, developed in partnership with Biogen, is an antibody that has been shown to remove sticky deposits of a protein called…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alzheimer’s drug
Eisai files for approval of Alzheimer’s drug in Europe
The drug, developed in partnership with Biogen, is an antibody that has been shown to remove sticky deposits of a protein called…
Roche’s Alzheimer’s drug fails to meet goal in long awaited trial
The Swiss drugmaker conducted two identically designed studies, each with about 1,000 participants, who were examined and queried…
Biogen raises annual profit forecast for second straight quarter
Data on the drug has been promising and Biogen and Eisai are expected to file for a US approval soon with a decision expected in…
Former FDA adviser calls for wider probe into Biogen Alzheimer’s drug approval
Acting FDA Commissioner Janet Woodcock earlier this month asked the Office of the Inspector General at the Department of Health…
Biogen applies for approval of Alzheimer’s drug, aducanumab in Japan
Biogen and Eisai have jointly developed three experimental drugs for Alzheimer’s
Biogen moves forward with potential Alzheimer’s drug, seeks US FDA’s approval
The drug, aducanumab, has had a tumultuous journey, with promising early data raising hopes and Biogen’s share price, only to be…
Biogen and Eisai revive plans for Alzheimer’s drug, surprising market
The field of experimental Alzheimer’s treatments is littered with high-profile failures, with many major drugmakers abandoning the…